Furthermore, via CSF1‐R and CD138, IL‐34 enhanced the proliferation and migration of HCC cells, and promoted the activation of signal pathways and the expression of associated proteins mediated by HBX. The gene discussed is IL34; the disease is hepatocellular carcinoma.